Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONCOVID: Hydroxychloroquine and Azithromycin in cancer patients with COVID-19
NCT04341207Phase 2Unknown
- Sponsor
- Gustave Roussy
- Start
- Apr 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Gustave Roussy. Status: unknown.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04341207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341207.